skip to Main Content
Phone: 301-655-1084 Email: info@glycorx.com

The licensing agreement will accelerate the development of therapeutics to treat drug-resistant metastatic colorectal cancer.

https://www.prnewswire.com/news-releases/university-of-maryland-baltimore-umb-grants-glycomantra-exclusive-license-to-advance-the-companys-therapeutic-pipeline-301494969.html

Back To Top